GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is a catalytic enzyme commonly involved in glycolysis. GAPDH exists as a tetramer of identical 37 kDa subunits and catalyzes reversible reduction of the...
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is a catalytic enzyme commonly involved in glycolysis. GAPDH exists as a tetramer of 37 kDa identical subunits and catalyses the reversible reduction of 1.3-bisphosphoglycerate to 3-phosphophate glyceraldehyde in the presence of NADPH. In addition to playing a key role in glycolysis, GAPDH is ubiquitous and has other activities unrelated to its glycolytic function. GAPDH is reported to be involved in the processes of replication of DNA, repair of DNA, export of nuclear RNA, membrane fusion and microtubule aggregation. The studies provide evidence that GAPDH plays an essential role in the genetic expression observed in the apoptosis and cell phenotype of age-related neurodegenerative diseases. In addition, GAPDH is involved in other cellular processes ranging from membrane fusion to neuronal apoptosis in cancer. GAPDH is reported to bind to a variety of other proteins, including the amyloid precursor protein, which mutations cause certain forms of Alzheimer's disease (MA), and the polyglutamine pathways of huntingtin, whose aberrant forms of the protein product are responsible for Huntington's disease. Associations between GAPDH, l-actin and tubulin have also been reported. Since GAPDH is expressed at high levels in most tissues, it is useful as a control of protein loading in Western transfer analysis.
Sensitivity
Sensitivity of dosage: 0.82 ng/ml.
Measurement range
Dosing range: 0.82 to 200 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Samples
Type of sample: Plasma, Serum, Surnatant (Surnatant volume, 50 μl-Plasma, 50 μl-Serum, 50 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17767603 |
| Specifications |
| Accession number | O14556, P04406 |
| Dose range | 0.82 to 200 ng/ml |
| Sensitivity of the dosage | 0.82 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 2597, 26330 |
| Gene symbol(s) | GAPDH, GAPDHS |
| Coefficient of inter-dose variation | < 12% |
| Coefficient of intra-dose variation | < 10% |
| Contents of kits | 96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate. |
| Marker or dye | HRP |
| Quantity | 10 x 96 tests |
| Regulatory status | RUO |
| Target | GAPDH analysis |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 μl-Plasma, 50 μl-Sera, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH207RBX10 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.